메뉴 건너뛰기




Volumn 50, Issue 5, 1996, Pages 287-

Maximal androgen blockade (MAB) for the treatment of prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; FLUTAMIDE; GONADORELIN DERIVATIVE;

EID: 0029825948     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (3)
  • 1
    • 0029963602 scopus 로고    scopus 로고
    • Recent advances in the médical management of prostate cancer
    • Kirby RS. Recent advances in the médical management of prostate cancer. Hr J Clin Pract 1996: 50(2): 88-93.
    • (1996) Hr J Clin Pract , vol.50 , Issue.2 , pp. 88-93
    • Kirby, R.S.1
  • 2
    • 0028864735 scopus 로고
    • A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer
    • Schellhammer P, Sharifi R, Block N et al. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Urolot> 1995; 45: 745-52.
    • (1995) Urolot> , vol.45 , pp. 745-752
    • Schellhammer, P.1    Sharifi, R.2    Block, N.3
  • 3
    • 0029618361 scopus 로고    scopus 로고
    • Worldwide activity and safety of bicalutamide: A summary review
    • Kolvenhag GJCM, Blackledge GRP. Worldwide activity and safety of bicalutamide: a summary review. Urology 1996:47:70-79.
    • (1996) Urology , vol.47 , pp. 70-79
    • Kolvenhag, G.J.C.1    Blackledge, G.R.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.